CSIMarket
 


Recursion Pharmaceuticals Inc   (RXRX)
Other Ticker:  
 

Recursion Pharmaceuticals Inc 's Total Debt to Equity

RXRX's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to debt repayement of -37.29% Recursion Pharmaceuticals Inc improved Total Debt to Equity in forth quarter 2023 to 0, a new company low.

Within Biotechnology & Pharmaceuticals industry Recursion Pharmaceuticals Inc achieved the lowest Total Debt to Equity in the forth quarter 2023. While Total Debt to Equity total ranking has improved so far in the forth quarter 2023 to 23, from total ranking in the third quarter 2023 at 54 .

Explain Debt to Equity Ratio?
What is the structure of RXRX´s Total Debt?
How valuable is the RXRX´s Equity?


RXRX Total Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -4.6 % 12.87 % 7.17 % -12.84 % -10.52 %
Y / Y Total Debt Change 80.41 % 177.59 % 169.66 % 162.11 % -12.45 %
Total Debt to Equity MRQ 0 0 0 0 0
RXRX's Total Ranking # 23 # 54 # 29 # 38 # 17
Seq. Equity Change 5.82 % -6.61 % 9.02 % -11.45 % 25.2 %
Seq. Total Debt Change -37.29 % -0.55 % -0.49 % 190.68 % -3.51 %



Total Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 5
Overall Market # 23


Total Debt to Equity Statistics
High Average Low
0.02 0 0
(Jun 30 2021)   (Sep 30 2021)




Financial Statements
Recursion Pharmaceuticals Inc 's Equity $ 463 Millions Visit RXRX's Balance sheet
Recursion Pharmaceuticals Inc 's Total Debt $ 1 Millions Visit RXRX's Balance sheet
Source of RXRX's Sales Visit RXRX's Sales by Geography


Cumulative Recursion Pharmaceuticals Inc 's Total Debt to Equity

RXRX's Total Debt to Equity for the trailling 12 Months

RXRX Total Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -4.6 % 12.87 % 7.17 % -12.84 % -10.52 %
Y / Y Total Debt TTM Growth 80.41 % 177.59 % 169.66 % 162.11 % -12.45 %
Total Debt to Equity TTM 0 0 0 0 0
Total Ranking TTM # 51 # 76 # 71 # 61 # 59
Seq. Equity TTM Growth 5.82 % -6.61 % 9.02 % -11.45 % 25.2 %
Seq. Total Debt TTM Growth -37.29 % -0.55 % -0.49 % 190.68 % -3.51 %


On the trailing twelve months basis Due to debt repayement of -37.29% Recursion Pharmaceuticals Inc